[Clinical study on the combined action of orphenadrine and thioproperazine: correction of neuroleptic impregnation and therapeutic synergism].
D014150:Antipsychotic Agents; D004347:Drug Interactions; D009966:Orphenadrine; D010276:Parasympatholytics / Q000628:therapy*; D010300:Parkinson Disease / Q000628:therapy*; D010640:Phenothiazines; D011600:Psychopharmacology / Q000150:complications*; D014149:Tranquilizing Agents / Q000628:therapy*
D014150:Antipsychotic Agents; D010276:Parasympatholytics; D010640:Phenothiazines; D014149:Tranquilizing Agents; D009966:Orphenadrine; C084825:thioproperazine
PARALYSIS AGITANS/therapy; PARASYMPATHOLYTICS/therapy; PSYCHOPHARMACOLOGY/complications; TRANQUILIZING AGENTS/therapy